PDF herunterladen
Semin Neurol 2011; 31(3): 286-306
DOI: 10.1055/s-0031-1287658
© Thieme Medical Publishers

Cerebrovascular Disease in Central Nervous System Infections

Felicia C. Chow1 , 2 , 3 , Christina M. Marra4 , Tracey A. Cho1 , 2 , 3
  • 1Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
  • 2Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
  • 3Harvard Medical School, Boston, Massachusetts
  • 4Department of Neurology, University of Washington, Seattle, Washington
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
30. September 2011 (online)

    Lizenzen und Reprints

ABSTRACT

Cerebrovascular disease is a complication of a variety of infections affecting the central nervous system (CNS). Infection may cause vasculitis affecting primarily the vessels at the base of the brain in the setting of meningitis; an immune-mediated parainfectious process leading to vasospasm or thrombosis; or a hypercoagulable state in combination with endothelial dysfunction resulting from activation of inflammatory and procoagulant cascades. Although systemic signs and symptoms may be present to aid in the diagnosis, cerebral infarction secondary to infection may be indistinguishable from more typical causes of stroke. Confirmation of an infectious vasculitis may also be challenging, as brain biopsy, the gold standard for diagnosis, is rarely pursued. In many CNS infections, vascular complications portend a poor prognosis as they are often associated with devastating neurologic outcomes, including death, underscoring the importance of early recognition and appropriate therapy. In this review, we address bacterial, viral, fungal, and parasitic causes of cerebrovascular disease.

KEYWORDS

Stroke - vasculitis - vasculopathy - cerebrovascular - infection - meningitis - central nervous system

REFERENCES

  • 1 Kiechl S, Egger G, Mayr M et al.. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study.  Circulation. 2001;  103 (8) 1064-1070
    CrossrefPubMedGoogle Scholar
  • 2 Elkind M SV, Ramakrishnan P, Moon Y P et al.. Infectious burden and risk of stroke: the northern Manhattan study.  Arch Neurol. 2010;  67 (1) 33-38
    CrossrefPubMedGoogle Scholar
  • 3 Grau A J, Brandt T. Do multiple chronic infections increase the risk of stroke?: the infectious burden concept.  Arch Neurol. 2010;  67 (1) 16-17
    CrossrefPubMedGoogle Scholar
  • 4 Thigpen M C, Whitney C G, Messonnier N E Emerging Infections Programs Network et al. Bacterial meningitis in the United States, 1998-2007.  N Engl J Med. 2011;  364 (21) 2016-2025
    CrossrefPubMedGoogle Scholar
  • 5 Durand M L, Calderwood S B, Weber D J et al.. Acute bacterial meningitis in adults. A review of 493 episodes.  N Engl J Med. 1993;  328 (1) 21-28
    CrossrefPubMedGoogle Scholar
  • 6 Kastenbauer S, Pfister H W. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases.  Brain. 2003;  126 (Pt 5) 1015-1025
    CrossrefPubMedGoogle Scholar
  • 7 Pfister H W, Borasio G D, Dirnagl U, Bauer M, Einhäupl K M. Cerebrovascular complications of bacterial meningitis in adults.  Neurology. 1992;  42 (8) 1497-1504
    CrossrefPubMedGoogle Scholar
  • 8 Weststrate W, Hijdra A, de Gans J. Brain infarcts in adults with bacterial meningitis.  Lancet. 1996;  347 (8998) 399
    PubMedGoogle Scholar
  • 9 van de Beek D, de Gans J, Tunkel A R, Wijdicks E FM. Community-acquired bacterial meningitis in adults.  N Engl J Med. 2006;  354 (1) 44-53
    CrossrefPubMedGoogle Scholar
  • 10 van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma J B, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis.  N Engl J Med. 2004;  351 (18) 1849-1859
    CrossrefPubMedGoogle Scholar
  • 11 Klein M, Koedel U, Kastenbauer S et al.. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis?.  Neurology. 2010;  75 (2) 193-194, author reply 193–194
    CrossrefPubMedGoogle Scholar
  • 12 van de Beek D, Patel R, Wijdicks E FM. Meningococcal meningitis with brainstem infarction.  Arch Neurol. 2007;  64 (9) 1350-1351
    CrossrefPubMedGoogle Scholar
  • 13 Schut E S, Brouwer M C, de Gans J, Florquin S, Troost D, van de Beek D. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis.  Neurology. 2009;  73 (23) 1988-1995
    CrossrefPubMedGoogle Scholar
  • 14 Levi M, van der Poll T, Büller H R. Bidirectional relation between inflammation and coagulation.  Circulation. 2004;  109 (22) 2698-2704
    CrossrefPubMedGoogle Scholar
  • 15 Vergouwen M DI, Schut E S, Troost D, van de Beek D. Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis.  Neurocrit Care. 2010;  13 (2) 217-227
    CrossrefPubMedGoogle Scholar
  • 16 Klein M, Koedel U, Kastenbauer S et al.. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis?.  Neurology. 2010;  75 (2) 193 author reply 193-194
    CrossrefPubMedGoogle Scholar
  • 17 Czartoski T, Hallam D, Lacy J M, Chun M R, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome.  J Neurol Neurosurg Psychiatry. 2005;  76 (2) 256-259
    CrossrefPubMedGoogle Scholar
  • 18 Pugin D, Copin J C, Goodyear M C, Landis T, Gasche Y. Persisting vasculitis after pneumococcal meningitis.  Neurocrit Care. 2006;  4 (3) 237-240
    CrossrefPubMedGoogle Scholar
  • 19 Tunkel A R, Hartman B J, Kaplan S L et al.. Practice guidelines for the management of bacterial meningitis.  Clin Infect Dis. 2004;  39 (9) 1267-1284
    CrossrefPubMedGoogle Scholar
  • 20 de Gans J, van de Beek D. European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators . Dexamethasone in adults with bacterial meningitis.  N Engl J Med. 2002;  347 (20) 1549-1556
    CrossrefPubMedGoogle Scholar
  • 21 van de Beek D, Farrar J J, de Gans J et al.. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data.  Lancet Neurol. 2010;  9 (3) 254-263
    CrossrefPubMedGoogle Scholar
  • 22 Brouwer M C, Heckenberg S G, de Gans J, Spanjaard L, Reitsma J B, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.  Neurology. 2010;  75 (17) 1533-1539
    CrossrefPubMedGoogle Scholar
  • 23 Brouwer M C, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis.  Cochrane Database Syst Rev. 2010;  (9) CD004405
    PubMedGoogle Scholar
  • 24 van de Beek D, Weisfelt M, de Gans J, Tunkel A R, Wijdicks E FM. Drug insight: adjunctive therapies in adults with bacterial meningitis.  Nat Clin Pract Neurol. 2006;  2 (9) 504-516
    PubMedGoogle Scholar
  • 25 World Health Organization .Global tuberculosis control 2010. Available at: http://www.who.int/tb/publications/global_report/2010/en/index.html Accessed June 1, 2011
    Google Scholar
  • 26 Christensen A S, Andersen A B, Thomsen V O, Andersen P H, Johansen I S. Tuberculous meningitis in Denmark: a review of 50 cases.  BMC Infect Dis. 2011;  11 47
    CrossrefPubMedGoogle Scholar
  • 27 Centers for Disease Control and Prevention .Reported tuberculosis in the United States 2009. Available at: http://www.cdc.gov/tb/statistics/reports/2009/pdf/report2009.pdf Accessed June 1, 2011
    Google Scholar
  • 28 Ogawa S K, Smith M A, Brennessel D J, Lowy F D. Tuberculous meningitis in an urban medical center.  Medicine (Baltimore). 1987;  66 (4) 317-326
    PubMedGoogle Scholar
  • 29 Kent S J, Crowe S M, Yung A, Lucas C R, Mijch A M. Tuberculous meningitis: a 30-year review.  Clin Infect Dis. 1993;  17 (6) 987-994
    CrossrefPubMedGoogle Scholar
  • 30 Girgis N I, Sultan Y, Farid Z et al.. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996.  Am J Trop Med Hyg. 1998;  58 (1) 28-34
    PubMedGoogle Scholar
  • 31 Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society . British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.  J Infect. 2009;  59 (3) 167-187
    CrossrefPubMedGoogle Scholar
  • 32 Dastur D K, Manghani D K, Udani P M. Pathology and pathogenetic mechanisms in neurotuberculosis.  Radiol Clin North Am. 1995;  33 (4) 733-752
    PubMedGoogle Scholar
  • 33 Katrak S M. Vasculitis and stroke due to tuberculosis. In: Caplan L R, ed. Uncommon Causes of Stroke. 2nd ed. New York: Cambridge University Press; 2008: 41-45
    Google Scholar
  • 34 Lammie G A, Hewlett R H, Schoeman J F, Donald P R. Tuberculous cerebrovascular disease: a review.  J Infect. 2009;  59 (3) 156-166
    CrossrefPubMedGoogle Scholar
  • 35 Misra U K, Kalita J, Maurya P K. Stroke in tuberculous meningitis.  J Neurol Sci. 2011;  303 (1-2) 22-30
    CrossrefPubMedGoogle Scholar
  • 36 Shukla R, Abbas A, Kumar P, Gupta R K, Jha S, Prasad K N. Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging.  J Infect. 2008;  57 (4) 298-306
    CrossrefPubMedGoogle Scholar
  • 37 Donald P R, Schoeman J F. Tuberculous meningitis.  N Engl J Med. 2004;  351 (17) 1719-1720
    CrossrefPubMedGoogle Scholar
  • 38 Kalita J, Misra U K, Nair P P. Predictors of stroke and its significance in the outcome of tuberculous meningitis.  J Stroke Cerebrovasc Dis. 2009;  18 (4) 251-258
    CrossrefPubMedGoogle Scholar
  • 39 Dalal P M, Dalal K P. Subcortical and lacunar infarctions in neurotuberculosis. In: Donnan G A, Norrving B, Bamford J M, Bogousslvsky J, eds. Lacunar and Other Subcortical Infarctions. New York: Oxford University Press; 1995: 219-230
    Google Scholar
  • 40 Rich A R, McCordock H A. The pathogenesis of tuberculous meningitis.  Bull Johns Hopkins Hosp. 1933;  53 5-37
    PubMedGoogle Scholar
  • 41 Brown E, Gray F. Bacterial infections. In: Love S, Louis D N, Ellison D W, eds. Greenfield's Neuropathology. 8th ed. London: Hodder Arnold; 2008: 1391-1445
    Google Scholar
  • 42 Dalal P M. Observations on the involvement of cerebral vessels in tuberculous meningitis in adults.  Adv Neurol. 1979;  25 149-159
    PubMedGoogle Scholar
  • 43 Rojas-Echeverri L A, Soto-Hernández J L, Garza S et al.. Predictive value of digital subtraction angiography in patients with tuberculous meningitis.  Neuroradiology. 1996;  38 (1) 20-24
    CrossrefPubMedGoogle Scholar
  • 44 Sütlaş P N, Unal A, Forta H, Senol S, Kirbaş D. Tuberculous meningitis in adults: review of 61 cases.  Infection. 2003;  31 (6) 387-391
    PubMedGoogle Scholar
  • 45 Jeren T, Beus I. Characteristics of cerebrospinal fluid in tuberculous meningitis.  Acta Cytol. 1982;  26 (5) 678-680
    PubMedGoogle Scholar
  • 46 Thwaites G E, Chau T T, Stepniewska K et al.. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features.  Lancet. 2002;  360 (9342) 1287-1292
    CrossrefPubMedGoogle Scholar
  • 47 Zuger A. Tuberculosis. In: Scheld W M, Whitley R J, Marra C M, eds. Infections of the Central Nervous System. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2004: 441-459
    Google Scholar
  • 48 Verdon R, Chevret S, Laissy J P, Wolff M. Tuberculous meningitis in adults: review of 48 cases.  Clin Infect Dis. 1996;  22 (6) 982-988
    CrossrefPubMedGoogle Scholar
  • 49 Thwaites G E, Chau T T, Farrar J J. Improving the bacteriological diagnosis of tuberculous meningitis.  J Clin Microbiol. 2004;  42 (1) 378-379
    CrossrefPubMedGoogle Scholar
  • 50 Thwaites G E, Caws M, Chau T T et al.. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy.  J Clin Microbiol. 2004;  42 (3) 996-1002
    CrossrefPubMedGoogle Scholar
  • 51 Pai M, Flores L L, Pai N, Hubbard A, Riley L W, Colford Jr J M. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis.  Lancet Infect Dis. 2003;  3 (10) 633-643
    CrossrefPubMedGoogle Scholar
  • 52 Hsieh F Y, Chia L G, Shen W C. Locations of cerebral infarctions in tuberculous meningitis.  Neuroradiology. 1992;  34 (3) 197-199
    CrossrefPubMedGoogle Scholar
  • 53 Nair P P, Kalita J, Kumar S, Misra U K. MRI pattern of infarcts in basal ganglia region in patients with tuberculous meningitis.  Neuroradiology. 2009;  51 (4) 221-225
    CrossrefPubMedGoogle Scholar
  • 54 Greitz T. Angiography in tuberculous meningitis.  Acta Radiol Diagn (Stockh). 1964;  2 369-378
    PubMedGoogle Scholar
  • 55 Lehrer H. The angiographic triad in tuberculous meningitis. A radiographic and clinicopathologic correlation.  Radiology. 1966;  87 (5) 829-835
    PubMedGoogle Scholar
  • 56 Mathew N T, Abraham J, Chandy J. Cerebral angiographic features in tuberculous meningitis.  Neurology. 1970;  20 (10) 1015-1023
    CrossrefPubMedGoogle Scholar
  • 57 Koh S B, Kim B J, Park M H, Yu S W, Park K W, Lee D H. Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study.  J Clin Neurosci. 2007;  14 (11) 1073-1077
    CrossrefPubMedGoogle Scholar
  • 58 Misra U K, Kalita J, Roy A K, Mandal S K, Srivastava M. Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysis.  J Neurol Neurosurg Psychiatry. 2000;  68 (3) 300-303
    CrossrefPubMedGoogle Scholar
  • 59 Berenguer J, Moreno S, Laguna F et al.. Tuberculous meningitis in patients infected with the human immunodeficiency virus.  N Engl J Med. 1992;  326 (10) 668-672
    CrossrefPubMedGoogle Scholar
  • 60 Dubé M P, Holtom P D, Larsen R A. Tuberculous meningitis in patients with and without human immunodeficiency virus infection.  Am J Med. 1992;  93 (5) 520-524
    CrossrefPubMedGoogle Scholar
  • 61 Porkert M T, Sotir M, Parrott-Moore P, Blumberg H M. Tuberculous meningitis at a large inner-city medical center.  Am J Med Sci. 1997;  313 (6) 325-331
    CrossrefPubMedGoogle Scholar
  • 62 Yechoor V K, Shandera W X, Rodriguez P, Cate T R. Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital.  Arch Intern Med. 1996;  156 (15) 1710-1716
    CrossrefPubMedGoogle Scholar
  • 63 Schutte C M. Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis.  Infection. 2001;  29 (4) 213-217
    CrossrefPubMedGoogle Scholar
  • 64 van der Weert E M, Hartgers N M, Schaaf H S et al.. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children.  Pediatr Infect Dis J. 2006;  25 (1) 65-69
    PubMedGoogle Scholar
  • 65 Jarvis J N, Meintjes G, Williams A, Brown Y, Crede T, Harrison T S. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases.  BMC Infect Dis. 2010;  10 67
    CrossrefPubMedGoogle Scholar
  • 66 Katrak S M, Shembalkar P K, Bijwe S R, Bhandarkar L D. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection.  J Neurol Sci. 2000;  181 (1-2) 118-126
    CrossrefPubMedGoogle Scholar
  • 67 Thwaites G E, Duc Bang N, Huy Dung N et al.. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis.  J Infect Dis. 2005;  192 (12) 2134-2141
    CrossrefPubMedGoogle Scholar
  • 68 Jones B E, Young S M, Antoniskis D, Davidson P T, Kramer F, Barnes P F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.  Am Rev Respir Dis. 1993;  148 (5) 1292-1297
    CrossrefPubMedGoogle Scholar
  • 69 American Thoracic Society . Treatment of tuberculosis.  MMWR Recomm Rep. 2003;  52 (RR-11) 1-77
    PubMedGoogle Scholar
  • 70 Thwaites G E, Nguyen D B, Nguyen H D et al.. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.  N Engl J Med. 2004;  351 (17) 1741-1751
    CrossrefPubMedGoogle Scholar
  • 71 Prasad K, Singh M B. Corticosteroids for managing tuberculous meningitis.  Cochrane Database Syst Rev. 2008;  (1) CD002244
    PubMedGoogle Scholar
  • 72 Marais S, Pepper D J, Schutz C, Wilkinson R J, Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting.  PLoS ONE. 2011;  6 (5) e20077
    CrossrefPubMedGoogle Scholar
  • 73 Teoh R, Humphries M J, O'Mahony G. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature.  Q J Med. 1987;  63 (241) 449-460
    PubMedGoogle Scholar
  • 74 Narita M, Ashkin D, Hollender E S, Pitchenik A E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.  Am J Respir Crit Care Med. 1998;  158 (1) 157-161
    CrossrefPubMedGoogle Scholar
  • 75 Pepper D J, Marais S, Maartens G et al.. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.  Clin Infect Dis. 2009;  48 (11) e96-e107
    CrossrefPubMedGoogle Scholar
  • 76 Thwaites G E, Macmullen-Price J, Tran T H et al.. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study.  Lancet Neurol. 2007;  6 (3) 230-236
    CrossrefPubMedGoogle Scholar
  • 77 Misra U K, Kalita J, Nair P P. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial.  J Neurol Sci. 2010;  293 (1-2) 12-17
    CrossrefPubMedGoogle Scholar
  • 78 CDC .Syphilis. Sexually Transmitted Diseases 2009. Available at: http://www.cdc.gov/std/stats09/syphilis.htm Accessed May 25, 2011
    Google Scholar
  • 79 Lukehart S A, Hook III E W, Baker-Zander S A, Collier A C, Critchlow C W, Handsfield H H. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.  Ann Intern Med. 1988;  109 (11) 855-862
    CrossrefPubMedGoogle Scholar
  • 80 Rolfs R T, Joesoef M R, Hendershot E F The Syphilis and HIV Study Group et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection.  N Engl J Med. 1997;  337 (5) 307-314
    CrossrefPubMedGoogle Scholar
  • 81 Merrit H H, Adams R D, Solomon H C. Neurosyphilis. New York: Oxford University Press; 1946
    Google Scholar
  • 82 Burke J M, Schaberg D R. Neurosyphilis in the antibiotic era.  Neurology. 1985;  35 (9) 1368-1371
    CrossrefPubMedGoogle Scholar
  • 83 Stokes J H, Beerman H, Ingraham N R. Modern Clinical Sphilology: Diagnosis, Treatment, Case Study. Philadelphia: WB Saunders; 1944
    Google Scholar
  • 84 Timmermans M, Carr J. Neurosyphilis in the modern era.  J Neurol Neurosurg Psychiatry. 2004;  75 (12) 1727-1730
    CrossrefPubMedGoogle Scholar
  • 85 Musher D M. Syphilis, neurosyphilis, penicillin, and AIDS.  J Infect Dis. 1991;  163 (6) 1201-1206
    CrossrefPubMedGoogle Scholar
  • 86 Holmes M D, Brant-Zawadzki M M, Simon R P. Clinical features of meningovascular syphilis.  Neurology. 1984;  34 (4) 553-556
    CrossrefPubMedGoogle Scholar
  • 87 Harriman D GF. Bacterial infections of the central nervous system. In: Blackwood W, Corsellis J AN, eds. Greenfield's Neuropathology. 3rd ed. Chicago: Yearbook Medical Publishers; 1976: 238-268
    Google Scholar
  • 88 Vatz K A, Scheibel R L, Keiffer S A, Ansari K A. Neurosyphilis and diffuse cerebral angiopathy: a case report.  Neurology. 1974;  24 (5) 472-476
    CrossrefPubMedGoogle Scholar
  • 89 Winkelman N W, Eckel J L. Productive endarteritis of the small cortical vessels in severe toxemias.  Brain. 1927;  50 (3–4) 608-623
    CrossrefPubMedGoogle Scholar
  • 90 Davis L E, Schmitt J W. Clinical significance of cerebrospinal fluid tests for neurosyphilis.  Ann Neurol. 1989;  25 (1) 50-55
    CrossrefPubMedGoogle Scholar
  • 91 Workowski K A, Berman S M. Centers for Disease Control and Prevention . Sexually transmitted diseases treatment guidelines, 2006.  MMWR Recomm Rep. 2006;  55 (RR-11) 1-94
    PubMedGoogle Scholar
  • 92 Jaffe H W, Larsen S A, Peters M, Jove D F, Lopez B, Schroeter A L. Tests for treponemal antibody in CSF.  Arch Intern Med. 1978;  138 (2) 252-255
    CrossrefPubMedGoogle Scholar
  • 93 Simon R P. Neurosyphilis.  Arch Neurol. 1985;  42 (6) 606-613
    CrossrefPubMedGoogle Scholar
  • 94 Marra C M, Maxwell C L, Collier A C, Robertson K R, Imrie A. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.  BMC Infect Dis. 2007;  7 37
    CrossrefPubMedGoogle Scholar
  • 95 Berry C D, Hooton T M, Collier A C, Lukehart S A. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection.  N Engl J Med. 1987;  316 (25) 1587-1589
    CrossrefPubMedGoogle Scholar
  • 96 Johns D R, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus.  N Engl J Med. 1987;  316 (25) 1569-1572
    CrossrefPubMedGoogle Scholar
  • 97 Katz D A, Berger J R, Duncan R C. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus.  Arch Neurol. 1993;  50 (3) 243-249
    CrossrefPubMedGoogle Scholar
  • 98 Centers for Disease Control and Prevention (CDC) . Symptomatic early neurosyphilis among HIV-positive men who have sex with men—four cities, United States, January 2002-June 2004.  MMWR Morb Mortal Wkly Rep. 2007;  56 (25) 625-628
    PubMedGoogle Scholar
  • 99 Chang C C, Leslie D E, Spelman D et al.. Symptomatic and asymptomatic early neurosyphilis in HIV-infected men who have sex with men: a retrospective case series from 2000 to 2007.  Sex Health. 2011;  8 (2) 207-213
    CrossrefPubMedGoogle Scholar
  • 100 Bucher J B, Golden M R, Heald A E, Marra C M. Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy.  Sex Transm Dis. 2010;  November 30 (Epub ahead of print)
    PubMedGoogle Scholar
  • 101 Marra C M, Maxwell C L, Smith S L et al.. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.  J Infect Dis. 2004;  189 (3) 369-376
    CrossrefPubMedGoogle Scholar
  • 102 Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. 2008. Available at: http://AIDSinfo.nih.gov Accessed May 28, 2009
    Google Scholar
  • 103 Ghanem K G, Erbelding E J, Wiener Z S, Rompalo A M. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics.  Sex Transm Infect. 2007;  83 (2) 97-101
    PubMedGoogle Scholar
  • 104 Kelley R E, Minagar A, Kelley B J, Brunson R. Trancranial Doppler monitoring of response to therapy for meningovascular syphilis.  J Neuroimaging. 2003;  13 (1) 85-87
    PubMedGoogle Scholar
  • 105 Davis L E, Graham G D. Neurosyphilis and stroke. In: Caplan L R, ed. Uncommon Causes of Stroke. 2nd ed. New York: Cambridge University Press; 2008: 35-39
    Google Scholar
  • 106 Askalan R, Laughlin S, Mayank S et al.. Chickenpox and stroke in childhood: a study of frequency and causation.  Stroke. 2001;  32 (6) 1257-1262
    CrossrefPubMedGoogle Scholar
  • 107 Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of childhood: natural history of vascular stenosis.  Neurology. 2005;  64 (4) 660-663
    CrossrefPubMedGoogle Scholar
  • 108 Miravet E, Danchaivijitr N, Basu H, Saunders D E, Ganesan V. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection.  Dev Med Child Neurol. 2007;  49 (6) 417-422
    CrossrefPubMedGoogle Scholar
  • 109 Manco-Johnson M J, Nuss R, Key N et al.. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis.  J Pediatr. 1996;  128 (3) 319-323
    CrossrefPubMedGoogle Scholar
  • 110 Massano J, Ferreira D, Toledo T, Mansilha A, Azevedo E, Carvalho M. Stroke and multiple peripheral thrombotic events in an adult with varicella.  Eur J Neurol. 2008;  15 (10) e90-e91
    CrossrefPubMedGoogle Scholar
  • 111 Josephson C, Nuss R, Jacobson L et al.. The varicella-autoantibody syndrome.  Pediatr Res. 2001;  50 (3) 345-352
    CrossrefPubMedGoogle Scholar
  • 112 Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections.  Curr Neurol Neurosci Rep. 2009;  9 (6) 430-434
    CrossrefPubMedGoogle Scholar
  • 113 Reshef E, Greenberg S B, Jankovic J. Herpes zoster ophthalmicus followed by contralateral hemiparesis: report of two cases and review of literature.  J Neurol Neurosurg Psychiatry. 1985;  48 (2) 122-127
    CrossrefPubMedGoogle Scholar
  • 114 Hilt D C, Buchholz D, Krumholz A, Weiss H, Wolinsky J S. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches.  Ann Neurol. 1983;  14 (5) 543-553
    CrossrefPubMedGoogle Scholar
  • 115 Nagel M A, Cohrs R J, Mahalingam R et al.. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.  Neurology. 2008;  70 (11) 853-860
    CrossrefPubMedGoogle Scholar
  • 116 Gray F, Bélec L, Lescs M C et al.. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome.  Brain. 1994;  117 (Pt 5) 987-999
    CrossrefPubMedGoogle Scholar
  • 117 Nagel M A, Mahalingam R, Cohrs R J, Gilden D. Virus vasculopathy and stroke: an under-recognized cause and treatment target.  Infect Disord Drug Targets. 2010;  10 (2) 105-111
    CrossrefPubMedGoogle Scholar
  • 118 Nagel M A, Forghani B, Mahalingam R et al.. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy.  Neurology. 2007;  68 (13) 1069-1073
    CrossrefPubMedGoogle Scholar
  • 119 Katchanov J, Siebert E, Klingebiel R, Endres M. Infectious vasculopathy of intracranial large- and medium-sized vessels in neurological intensive care unit: a clinico-radiological study.  Neurocrit Care. 2010;  12 (3) 369-374
    CrossrefPubMedGoogle Scholar
  • 120 Schmidbauer M, Budka H, Pilz P, Kurata T, Hondo R. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues.  Brain. 1992;  115 (Pt 2) 383-398
    CrossrefPubMedGoogle Scholar
  • 121 Kleinschmidt-DeMasters B K, Amlie-Lefond C, Gilden D H. The patterns of varicella zoster virus encephalitis.  Hum Pathol. 1996;  27 (9) 927-938
    CrossrefPubMedGoogle Scholar
  • 122 Ruppenthal M. Changes of the central nervous system in herpes zoster.  Acta Neuropathol. 1980;  52 (1) 59-68
    CrossrefPubMedGoogle Scholar
  • 123 Gilden D H, Kleinschmidt-DeMasters B K, LaGuardia J J, Mahalingam R, Cohrs R J. Neurologic complications of the reactivation of varicella-zoster virus.  N Engl J Med. 2000;  342 (9) 635-645
    CrossrefPubMedGoogle Scholar
  • 124 Gilden D, Cohrs R J, Mahalingam R, Nagel M A. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.  Lancet Neurol. 2009;  8 (8) 731-740
    CrossrefPubMedGoogle Scholar
  • 125 Newsome S D, Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids.  J Neurovirol. 2009;  15 (3) 288-291
    CrossrefPubMedGoogle Scholar
  • 126 Oxman M N, Levin M J, Johnson G R Shingles Prevention Study Group et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.  N Engl J Med. 2005;  352 (22) 2271-2284
    CrossrefPubMedGoogle Scholar
  • 127 Triant V A, Lee H, Hadigan C, Grinspoon S K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.  J Clin Endocrinol Metab. 2007;  92 (7) 2506-2512
    CrossrefPubMedGoogle Scholar
  • 128 Currier J S, Taylor A, Boyd F et al.. Coronary heart disease in HIV-infected individuals.  J Acquir Immune Defic Syndr. 2003;  33 (4) 506-512
    CrossrefPubMedGoogle Scholar
  • 129 Friis-Møller N, Sabin C A, Weber R Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group et al. Combination antiretroviral therapy and the risk of myocardial infarction.  N Engl J Med. 2003;  349 (21) 1993-2003
    CrossrefPubMedGoogle Scholar
  • 130 Berger J R, Harris J O, Gregorios J, Norenberg M. Cerebrovascular disease in AIDS: a case-control study.  AIDS. 1990;  4 (3) 239-244
    CrossrefPubMedGoogle Scholar
  • 131 Cole J W, Pinto A N, Hebel J R et al.. Acquired immunodeficiency syndrome and the risk of stroke.  Stroke. 2004;  35 (1) 51-56
    PubMedGoogle Scholar
  • 132 Engstrom J W, Lowenstein D H, Bredesen D E. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome.  Am J Med. 1989;  86 (5) 528-532
    CrossrefPubMedGoogle Scholar
  • 133 Pinto A N. AIDS and cerebrovascular disease.  Stroke. 1996;  27 (3) 538-543
    CrossrefPubMedGoogle Scholar
  • 134 Anders K H, Guerra W F, Tomiyasu U, Verity M A, Vinters H V. The neuropathology of AIDS. UCLA experience and review.  Am J Pathol. 1986;  124 (3) 537-558
    PubMedGoogle Scholar
  • 135 Mizusawa H, Hirano A, Llena J F, Shintaku M. Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS).  Acta Neuropathol. 1988;  76 (5) 451-457
    CrossrefPubMedGoogle Scholar
  • 136 Connor M D, Lammie G A, Bell J E, Warlow C P, Simmonds P, Brettle R D. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort.  Stroke. 2000;  31 (9) 2117-2126
    CrossrefPubMedGoogle Scholar
  • 137 Gray F, Gherardi R, Scaravilli F. The neuropathology of the acquired immune deficiency syndrome (AIDS). A review.  Brain. 1988;  111 (Pt 2) 245-266
    CrossrefPubMedGoogle Scholar
  • 138 Evers S, Nabavi D, Rahmann A, Heese C, Reichelt D, Husstedt I W. Ischaemic cerebrovascular events in HIV infection: a cohort study.  Cerebrovasc Dis. 2003;  15 (3) 199-205
    CrossrefPubMedGoogle Scholar
  • 139 Corral I, Quereda C, Moreno A et al.. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.  Cerebrovasc Dis. 2009;  27 (6) 559-563
    CrossrefPubMedGoogle Scholar
  • 140 Berger J R. AIDS and stroke risk.  Lancet Neurol. 2004;  3 (4) 206-207
    CrossrefPubMedGoogle Scholar
  • 141 Ovbiagele B, Nath A. Increasing incidence of ischemic stroke in patients with HIV infection.  Neurology. 2011;  January 19 (Epub ahead of print)
    PubMedGoogle Scholar
  • 142 Chetty R. Vasculitides associated with HIV infection.  J Clin Pathol. 2001;  54 (4) 275-278
    CrossrefPubMedGoogle Scholar
  • 143 Calabrese L H, Estes M, Yen-Lieberman B et al.. Systemic vasculitis in association with human immunodeficiency virus infection.  Arthritis Rheum. 1989;  32 (5) 569-576
    CrossrefPubMedGoogle Scholar
  • 144 Calabrese L H. Vasculitis and infection with the human immunodeficiency virus.  Rheum Dis Clin North Am. 1991;  17 (1) 131-147
    PubMedGoogle Scholar
  • 145 Anders K H, Latta H, Chang B S, Tomiyasu U, Quddusi A S, Vinters H V. Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome.  Hum Pathol. 1989;  20 (4) 326-334
    CrossrefPubMedGoogle Scholar
  • 146 Calabrese L H. Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease.  Clin Exp Rheumatol. 2004;  22 (6, Suppl 36) S87-S93
    PubMedGoogle Scholar
  • 147 Nogueras C, Sala M, Sasal M et al.. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus.  Arch Neurol. 2002;  59 (3) 468-473
    CrossrefPubMedGoogle Scholar
  • 148 Melica G, Brugieres P, Lascaux A S, Levy Y, Lelièvre J D. Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era.  J Med Virol. 2009;  81 (4) 578-581
    CrossrefPubMedGoogle Scholar
  • 149 Frank Y, Lim W, Kahn E, Farmer P, Gorey M, Pahwa S. Multiple ischemic infarcts in a child with AIDS, varicella zoster infection, and cerebral vasculitis.  Pediatr Neurol. 1989;  5 (1) 64-67
    CrossrefPubMedGoogle Scholar
  • 150 Yankner B A, Skolnik P R, Shoukimas G M, Gabuzda D H, Sobel R A, Ho D D. Cerebral granulomatous angiitis associated with isolation of human T-lymphotropic virus type III from the central nervous system.  Ann Neurol. 1986;  20 (3) 362-364
    CrossrefPubMedGoogle Scholar
  • 151 Bhagavati S, Choi J. Rapidly progressive cerebrovascular stenosis and recurrent strokes followed by improvement in HIV vasculopathy.  Cerebrovasc Dis. 2008;  26 (4) 449-452
    CrossrefPubMedGoogle Scholar
  • 152 Gillams A R, Allen E, Hrieb K, Venna N, Craven D, Carter A P. Cerebral infarction in patients with AIDS.  AJNR Am J Neuroradiol. 1997;  18 (8) 1581-1585
    PubMedGoogle Scholar
  • 153 Vinters H V, Guerra W F, Eppolito L, Keith III P E. Necrotizing vasculitis of the nervous system in a patient with AIDS-related complex.  Neuropathol Appl Neurobiol. 1988;  14 (5) 417-424
    CrossrefPubMedGoogle Scholar
  • 154 Scaravilli F, Daniel S E, Harcourt-Webster N, Guiloff R J. Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome. A possible role for human immunodeficiency virus.  Arch Pathol Lab Med. 1989;  113 (2) 192-195
    PubMedGoogle Scholar
  • 155 Burns D K. The neuropathology of pediatric acquired immunodeficiency syndrome.  J Child Neurol. 1992;  7 (4) 332-346
    CrossrefPubMedGoogle Scholar
  • 156 Park Y D, Belman A L, Kim T S et al.. Stroke in pediatric acquired immunodeficiency syndrome.  Ann Neurol. 1990;  28 (3) 303-311
    CrossrefPubMedGoogle Scholar
  • 157 Dubrovsky T, Curless R, Scott G et al.. Cerebral aneurysmal arteriopathy in childhood AIDS.  Neurology. 1998;  51 (2) 560-565
    CrossrefPubMedGoogle Scholar
  • 158 Martínez-Longoria C A, Morales-Aguirre J J, Villalobos-Acosta C P, Gómez-Barreto D, Cashat-Cruz M. Occurrence of intracerebral aneurysm in an HIV-infected child: a case report.  Pediatr Neurol. 2004;  31 (2) 130-132
    CrossrefPubMedGoogle Scholar
  • 159 Mazzoni P, Chiriboga C A, Millar W S, Rogers A. Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review.  Pediatr Neurol. 2000;  23 (3) 252-255
    CrossrefPubMedGoogle Scholar
  • 160 Patsalides A D, Wood L V, Atac G K, Sandifer E, Butman J A, Patronas N J. Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings.  AJR Am J Roentgenol. 2002;  179 (4) 999-1003
    CrossrefPubMedGoogle Scholar
  • 161 Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma.  Hum Pathol. 2000;  31 (3) 374-379
    CrossrefPubMedGoogle Scholar
  • 162 Tipping B, de Villiers L, Candy S, Wainwright H. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy.  Arch Neurol. 2006;  63 (11) 1640-1642
    CrossrefPubMedGoogle Scholar
  • 163 Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A. Stroke in patients with human immunodeficiency virus infection.  J Neurol Neurosurg Psychiatry. 2007;  78 (12) 1320-1324
    CrossrefPubMedGoogle Scholar
  • 164 Qureshi A I, Janssen R S, Karon J M et al.. Human immunodeficiency virus infection and stroke in young patients.  Arch Neurol. 1997;  54 (9) 1150-1153
    CrossrefPubMedGoogle Scholar
  • 165 Mochan A, Modi M, Modi G. Stroke in black South African HIV-positive patients: a prospective analysis.  Stroke. 2003;  34 (1) 10-15
    CrossrefPubMedGoogle Scholar
  • 166 Mochan A, Modi M, Modi G. Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection.  J Neurol Neurosurg Psychiatry. 2005;  76 (10) 1455-1456
    CrossrefPubMedGoogle Scholar
  • 167 Ortiz G, Koch S, Romano J G, Forteza A M, Rabinstein A A. Mechanisms of ischemic stroke in HIV-infected patients.  Neurology. 2007;  68 (16) 1257-1261
    CrossrefPubMedGoogle Scholar
  • 168 Stein J H. Dyslipidemia in the era of HIV protease inhibitors.  Prog Cardiovasc Dis. 2003;  45 (4) 293-304
    PubMedGoogle Scholar
  • 169 Walli R, Herfort O, Michl G M et al.. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.  AIDS. 1998;  12 (15) F167-F173
    CrossrefPubMedGoogle Scholar
  • 170 Périard D, Telenti A, Sudre P et al.. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.  Circulation. 1999;  100 (7) 700-705
    CrossrefPubMedGoogle Scholar
  • 171 Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management.  AIDS. 2003;  17 (Suppl 1) S141-S148
    CrossrefPubMedGoogle Scholar
  • 172 Chen D, Misra A, Garg A. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.  J Clin Endocrinol Metab. 2002;  87 (11) 4845-4856
    CrossrefPubMedGoogle Scholar
  • 173 Saif M W, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients.  AIDS Patient Care STDS. 2001;  15 (6) 311-320
    CrossrefPubMedGoogle Scholar
  • 174 Fantoni M, Del Borgo C, Autore C. Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy.  AIDS. 2003;  17 (Suppl 1) S162-S169
    CrossrefPubMedGoogle Scholar
  • 175 Bozzette S A, Ake C F, Tam H K et al.. Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy.  J Acquir Immune Defic Syndr. 2008;  47 (3) 338-341
    PubMedGoogle Scholar
  • 176 Currier J S, Kendall M A, Zackin R AACTG 5078 Study Team et al. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.  AIDS. 2005;  19 (9) 927-933
    CrossrefPubMedGoogle Scholar
  • 177 El-Sadr W M, Lundgren J D, Neaton J D Strategies for Management of Antiretroviral Therapy (SMART) Study Group et al. CD4 + count-guided interruption of antiretroviral treatment.  N Engl J Med. 2006;  355 (22) 2283-2296
    CrossrefPubMedGoogle Scholar
  • 178 Mercié P, Thiébaut R, Lavignolle V et al.. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.  Ann Med. 2002;  34 (1) 55-63
    CrossrefPubMedGoogle Scholar
  • 179 Seaberg E C, Benning L, Sharrett A R et al.. Association between human immunodeficiency virus infection and stiffness of the common carotid artery.  Stroke. 2010;  41 (10) 2163-2170
    CrossrefPubMedGoogle Scholar
  • 180 Denning D W. Invasive aspergillosis.  Clin Infect Dis. 1998;  26 (4) 781-803 quiz 804-805
    CrossrefPubMedGoogle Scholar
  • 181 Torre-Cisneros J, Lopez O L, Kusne S et al.. CNS aspergillosis in organ transplantation: a clinicopathological study.  J Neurol Neurosurg Psychiatry. 1993;  56 (2) 188-193
    CrossrefPubMedGoogle Scholar
  • 182 Walsh T J, Hier D B, Caplan L R. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.  Ann Neurol. 1985;  18 (5) 574-582
    CrossrefPubMedGoogle Scholar
  • 183 Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients.  J Hosp Infect. 2002;  50 (3) 175-182
    CrossrefPubMedGoogle Scholar
  • 184 Kleinschmidt-DeMasters B K. Central nervous system aspergillosis: a 20-year retrospective series.  Hum Pathol. 2002;  33 (1) 116-124
    CrossrefPubMedGoogle Scholar
  • 185 Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, Witoonpanich R, Sungkanuparph S, Vibhagool A. Aspergillosis of the central nervous system: a catastrophic opportunistic infection.  Southeast Asian J Trop Med Public Health. 2004;  35 (1) 119-125
    PubMedGoogle Scholar
  • 186 Lin S J, Schranz J, Teutsch S M. Aspergillosis case-fatality rate: systematic review of the literature.  Clin Infect Dis. 2001;  32 (3) 358-366
    CrossrefPubMedGoogle Scholar
  • 187 Denning D W. Therapeutic outcome in invasive aspergillosis.  Clin Infect Dis. 1996;  23 (3) 608-615
    CrossrefPubMedGoogle Scholar
  • 188 Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis.  Ann Hematol. 2004;  83 (Suppl 1) S42-S44
    PubMedGoogle Scholar
  • 189 Sood S, Sharma R, Gupta S, Pathak D, Rishi S. Neuroaspergillosis in an immunocompetent patient.  Indian J Med Microbiol. 2007;  25 (1) 67-69
    CrossrefPubMedGoogle Scholar
  • 190 Martins H S, da Silva T R, Scalabrini-Neto A, Velasco I T. Cerebral vasculitis caused by Aspergillus simulating ischemic stroke in an immunocompetent patient.  J Emerg Med. 2010;  38 (5) 597-600
    CrossrefPubMedGoogle Scholar
  • 191 Murthy J M, Sundaram C, Prasad V S, Purohit A K, Rammurti S, Laxmi V. Aspergillosis of central nervous system: a study of 21 patients seen in a university hospital in south India.  J Assoc Physicians India. 2000;  48 (7) 677-681
    PubMedGoogle Scholar
  • 192 Ho C L, Deruytter M J. CNS aspergillosis with mycotic aneurysm, cerebral granuloma and infarction.  Acta Neurochir (Wien). 2004;  146 (8) 1-6
    CrossrefPubMedGoogle Scholar
  • 193 Hagensee M E, Bauwens J E, Kjos B, Bowden R A. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.  Clin Infect Dis. 1994;  19 (3) 402-408
    CrossrefPubMedGoogle Scholar
  • 194 Hummel M, Spiess B, Kentouche K et al.. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay.  J Clin Microbiol. 2006;  44 (11) 3989-3993
    CrossrefPubMedGoogle Scholar
  • 195 Kami M, Shirouzu I, Mitani K et al.. Early diagnosis of central nervous system aspergillosis with combination use of cerebral diffusion-weighted echo-planar magnetic resonance image and polymerase chain reaction of cerebrospinal fluid.  Intern Med. 1999;  38 (1) 45-48
    CrossrefPubMedGoogle Scholar
  • 196 Wheat L J. Rapid diagnosis of invasive aspergillosis by antigen detection.  Transpl Infect Dis. 2003;  5 (4) 158-166
    CrossrefPubMedGoogle Scholar
  • 197 Musher B, Fredricks D, Leisenring W, Balajee S A, Smith C, Marr K A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.  J Clin Microbiol. 2004;  42 (12) 5517-5522
    CrossrefPubMedGoogle Scholar
  • 198 Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections.  J Clin Microbiol. 2008;  46 (3) 1009-1013
    CrossrefPubMedGoogle Scholar
  • 199 Viscoli C, Machetti M, Gazzola P et al.. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis.  J Clin Microbiol. 2002;  40 (4) 1496-1499
    CrossrefPubMedGoogle Scholar
  • 200 Miaux Y, Ribaud P, Williams M et al.. MR of cerebral aspergillosis in patients who have had bone marrow transplantation.  AJNR Am J Neuroradiol. 1995;  16 (3) 555-562
    PubMedGoogle Scholar
  • 201 Gabelmann A, Klein S, Kern W et al.. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients.  Eur J Neurol. 2007;  14 (5) 548-555
    CrossrefPubMedGoogle Scholar
  • 202 Hurst R W, Judkins A, Bolger W, Chu A, Loevner L A. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation.  AJNR Am J Neuroradiol. 2001;  22 (5) 858-863
    PubMedGoogle Scholar
  • 203 Endo T, Tominaga T, Konno H, Yoshimoto T. Fatal subarachnoid hemorrhage, with brainstem and cerebellar infarction, caused by Aspergillus infection after cerebral aneurysm surgery: case report.  Neurosurgery. 2002;  50 (5) 1147-1150 discussion 1150-1151
    CrossrefPubMedGoogle Scholar
  • 204 Iihara K, Makita Y, Nabeshima S, Tei T, Keyaki A, Nioka H. Aspergillosis of the central nervous system causing subarachnoid hemorrhage from mycotic aneurysm of the basilar artery—case report.  Neurol Med Chir (Tokyo). 1990;  30 (8) 618-623
    CrossrefPubMedGoogle Scholar
  • 205 Schwartz S, Ruhnke M, Ribaud P et al.. Improved outcome in central nervous system aspergillosis, using voriconazole treatment.  Blood. 2005;  106 (8) 2641-2645
    CrossrefPubMedGoogle Scholar
  • 206 Radner A B, Witt M D, Edwards Jr J E. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review.  Clin Infect Dis. 1995;  20 (1) 163-166
    CrossrefPubMedGoogle Scholar
  • 207 Press G A, Weindling S M, Hesselink J R, Ochi J W, Harris J P. Rhinocerebral mucormycosis: MR manifestations.  J Comput Assist Tomogr. 1988;  12 (5) 744-749
    CrossrefPubMedGoogle Scholar
  • 208 Calli C, Savas R, Parildar M, Pekindil G, Alper H, Yunten N. Isolated pontine infarction due to rhinocerebral mucormycosis.  Neuroradiology. 1999;  41 (3) 179-181
    CrossrefPubMedGoogle Scholar
  • 209 Rangel-Guerra R A, Martínez H R, Sáenz C, Bosques-Padilla F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases.  J Neurol Sci. 1996;  143 (1-2) 19-30
    CrossrefPubMedGoogle Scholar
  • 210 Pagano L, Ricci P, Tonso A et al.. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).  Br J Haematol. 1997;  99 (2) 331-336
    CrossrefPubMedGoogle Scholar
  • 211 Escobar A, Del Brutto O H. Multiple brain abscesses from isolated cerebral mucormycosis.  J Neurol Neurosurg Psychiatry. 1990;  53 (5) 431-433
    CrossrefPubMedGoogle Scholar
  • 212 Cuadrado L M, Guerrero A, Garcia Asenjo J A, Martin F, Palau E, Garcia Urra D. Cerebral mucormycosis in two cases of acquired immunodeficiency syndrome.  Arch Neurol. 1988;  45 (1) 109-111
    CrossrefPubMedGoogle Scholar
  • 213 Hopkins R J, Rothman M, Fiore A, Goldblum S E. Cerebral mucormycosis associated with intravenous drug use: three case reports and review.  Clin Infect Dis. 1994;  19 (6) 1133-1137
    CrossrefPubMedGoogle Scholar
  • 214 Zarei M, Morris J, Aachi V, Gregory R, Meanock C, Brito-Babapulle F. Acute isolated cerebral mucormycosis in a patient with high grade non-Hodgkins lymphoma.  Eur J Neurol. 2000;  7 (4) 443-447
    CrossrefPubMedGoogle Scholar
  • 215 Yousem D M, Galetta S L, Gusnard D A, Goldberg H I. MR findings in rhinocerebral mucormycosis.  J Comput Assist Tomogr. 1989;  13 (5) 878-882
    CrossrefPubMedGoogle Scholar
  • 216 Galetta S L, Wulc A E, Goldberg H I, Nichols C W, Glaser J S. Rhinocerebral mucormycosis: management and survival after carotid occlusion.  Ann Neurol. 1990;  28 (1) 103-107
    CrossrefPubMedGoogle Scholar
  • 217 Lazo A, Wilner H I, Metes J J. Craniofacial mucormycosis: computed tomographic and angiographic findings in two cases.  Radiology. 1981;  139 (3) 623-626
    PubMedGoogle Scholar
  • 218 Mischel P S, Vinters H V. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates.  Clin Infect Dis. 1995;  20 (2) 400-405
    CrossrefPubMedGoogle Scholar
  • 219 Mathisen G, Shelub A, Truong J, Wigen C. Coccidioidal meningitis: clinical presentation and management in the fluconazole era.  Medicine (Baltimore). 2010;  89 (5) 251-284
    CrossrefPubMedGoogle Scholar
  • 220 Sobel R A, Ellis W G, Nielsen S L, Davis R L. Central nervous system coccidioidomycosis: a clinicopathologic study of treatment with and without amphotericin B.  Hum Pathol. 1984;  15 (10) 980-995
    CrossrefPubMedGoogle Scholar
  • 221 Mathisen G, Shelub A, Truong J, Wigen C. Coccidioidal meningitis: clinical presentation and management in the fluconazole era.  Medicine (Baltimore). 2010;  89 (5) 251-284
    CrossrefPubMedGoogle Scholar
  • 222 Williams P L, Johnson R, Pappagianis D et al.. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review.  Clin Infect Dis. 1992;  14 (3) 673-682
    CrossrefPubMedGoogle Scholar
  • 223 Arsura E L, Johnson R, Penrose J et al.. Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis.  Clin Infect Dis. 2005;  40 (4) 624-627
    CrossrefPubMedGoogle Scholar
  • 224 de Carvalho C A, Allen J N, Zafranis A, Yates A J. Coccidioidal meningitis complicated by cerebral arteritis and infarction.  Hum Pathol. 1980;  11 (3) 293-296
    CrossrefPubMedGoogle Scholar
  • 225 Johnson R H, Einstein H E. Coccidioidal meningitis.  Clin Infect Dis. 2006;  42 (1) 103-107
    CrossrefPubMedGoogle Scholar
  • 226 Drake K W, Adam R D. Coccidioidal meningitis and brain abscesses: analysis of 71 cases at a referral center.  Neurology. 2009;  73 (21) 1780-1786
    CrossrefPubMedGoogle Scholar
  • 227 Ragland A S, Arsura E, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance.  Am J Med. 1993;  95 (3) 254-257
    CrossrefPubMedGoogle Scholar
  • 228 Blair J E, Coakley B, Santelli A C, Hentz J G, Wengenack N L. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.  Mycopathologia. 2006;  162 (5) 317-324
    CrossrefPubMedGoogle Scholar
  • 229 Williams P L. Vasculitic complications associated with coccidioidal meningitis.  Semin Respir Infect. 2001;  16 (4) 270-279
    CrossrefPubMedGoogle Scholar
  • 230 Galgiani J N, Ampel N M, Blair J E Infectious Diseases Society of America et al. Coccidioidomycosis.  Clin Infect Dis. 2005;  41 (9) 1217-1223
    CrossrefPubMedGoogle Scholar
  • 231 Cortez K J, Walsh T J, Bennett J E. Successful treatment of coccidioidal meningitis with voriconazole.  Clin Infect Dis. 2003;  36 (12) 1619-1622
    CrossrefPubMedGoogle Scholar
  • 232 Wheat L J, Batteiger B E, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review.  Medicine (Baltimore). 1990;  69 (4) 244-260
    CrossrefPubMedGoogle Scholar
  • 233 Saccente M. Central nervous system histoplasmosis.  Curr Treat Options Neurol. 2008;  10 (3) 161-167
    CrossrefPubMedGoogle Scholar
  • 234 Carod-Artal F J, Venturini M, Gomes E, de Mello M T. [Chronic central nervous system histoplasmosis in an immunocompetent patient].  Neurologia. 2008;  23 (4) 263-268
    PubMedGoogle Scholar
  • 235 Wheat L J, Musial C E, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis.  Clin Infect Dis. 2005;  40 (6) 844-852
    CrossrefPubMedGoogle Scholar
  • 236 Mitchell D H, Sorrell T C, Allworth A M et al.. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.  Clin Infect Dis. 1995;  20 (3) 611-616
    CrossrefPubMedGoogle Scholar
  • 237 Shih C C, Chen Y C, Chang S C, Luh K T, Hsieh W C. Cryptococcal meningitis in non-HIV-infected patients.  QJM. 2000;  93 (4) 245-251
    CrossrefPubMedGoogle Scholar
  • 238 Tjia T L, Yeow Y K, Tan C B. Cryptococcal meningitis.  J Neurol Neurosurg Psychiatry. 1985;  48 (9) 853-858
    CrossrefPubMedGoogle Scholar
  • 239 Lan S H, Chang W N, Lu C H, Lui C C, Chang H W. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis.  QJM. 2001;  94 (5) 247-253
    CrossrefPubMedGoogle Scholar
  • 240 Chen S, Sorrell T, Nimmo G Australasian Cryptococcal Study Group et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand.  Clin Infect Dis. 2000;  31 (2) 499-508
    CrossrefPubMedGoogle Scholar
  • 241 Lane M, McBride J, Archer J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.  Neurology. 2004;  63 (4) 713-714
    CrossrefPubMedGoogle Scholar
  • 242 Saag M S, Graybill R J, Larsen R A Infectious Diseases Society of America et al. Practice guidelines for the management of cryptococcal disease.  Clin Infect Dis. 2000;  30 (4) 710-718
    CrossrefPubMedGoogle Scholar
  • 243 Garcia H H, Gonzalez A E, Gilman R H. Cysticerosis Working Group in Peru . Diagnosis, treatment and control of Taenia solium cysticercosis.  Curr Opin Infect Dis. 2003;  16 (5) 411-419
    CrossrefPubMedGoogle Scholar
  • 244 Alarcón F, Hidalgo F, Moncayo J, Viñán I, Dueñas G. Cerebral cysticercosis and stroke.  Stroke. 1992;  23 (2) 224-228
    CrossrefPubMedGoogle Scholar
  • 245 Del Brutto O H. Cysticercosis and cerebrovascular disease: a review.  J Neurol Neurosurg Psychiatry. 1992;  55 (4) 252-254
    CrossrefPubMedGoogle Scholar
  • 246 Scharf D. Neurocysticercosis. Two hundred thirty-eight cases from a California hospital.  Arch Neurol. 1988;  45 (7) 777-780
    CrossrefPubMedGoogle Scholar
  • 247 Barinagarrementeria F, Cantú C. Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study.  Stroke. 1998;  29 (1) 123-125
    CrossrefPubMedGoogle Scholar
  • 248 Alarcón F, Vanormelingen K, Moncayo J, Viñán I. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people.  Stroke. 1992;  23 (11) 1563-1565
    CrossrefPubMedGoogle Scholar
  • 249 Del Brutto O, Barinagarrementeria F. Inflammatory arteriopathies and pure motor hemiplegia.  Arch Neurol. 1989;  46 (4) 361
    PubMedGoogle Scholar
  • 250 Rodriguez-Carbajal J, Del Brutto O H, Penagos P, Huebe J, Escobar A. Occlusion of the middle cerebral artery due to cysticercotic angiitis.  Stroke. 1989;  20 (8) 1095-1099
    CrossrefPubMedGoogle Scholar
  • 251 Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum.  Arch Neurol. 1996;  53 (3) 233-239
    CrossrefPubMedGoogle Scholar
  • 252 Patel R, Jha S, Yadav R K. Pleomorphism of the clinical manifestations of neurocysticercosis.  Trans R Soc Trop Med Hyg. 2006;  100 (2) 134-141
    CrossrefPubMedGoogle Scholar
  • 253 Bouldin A, Pinter J D. Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone.  J Child Neurol. 2006;  21 (12) 1064-1067
    CrossrefPubMedGoogle Scholar
  • 254 Cantú C, Villarreal J, Soto J L, Barinagarrementeria F. Cerebral cysticercotic arteritis: detection and follow-up by transcranial Doppler.  Cerebrovasc Dis. 1998;  8 (1) 2-7
    PubMedGoogle Scholar
  • 255 Viola G M, White Jr A C, Serpa J A. Hemorrhagic cerebrovascular events and neurocysticercosis: a case report and review of the literature.  Am J Trop Med Hyg. 2011;  84 (3) 402-405
    CrossrefPubMedGoogle Scholar
  • 256 García H H, Evans C AW, Nash T E et al.. Current consensus guidelines for treatment of neurocysticercosis.  Clin Microbiol Rev. 2002;  15 (4) 747-756
    CrossrefPubMedGoogle Scholar

Tracey A ChoM.D. 

MGH Neurology, 55 Fruit Street

Boston, MA 02114

eMail: tcho@partners.org